# Entelexo Biotherapeutics Inc. — Form C/A (Regulation Crowdfunding)

Entelexo Biotherapeutics Inc. of Irvine, CA filed a Form C/A (Regulation Crowdfunding) with the SEC on 2021-07-02. Target raise $20K, up to $1.1M. Offered through Wefunder Portal LLC.

## Offering

- Filed: 2021-07-02
- Form: C/A
- Accession: 0001670254-21-000769
- Target amount: $20K
- Maximum amount: $1.1M
- Security type: Other
- Securities offered: 20,000
- Price: $1.0000
- Deadline: 2022-04-30
- Funding portal / intermediary: Wefunder Portal LLC
- Intermediary file number: 007-00033
- Intermediary CRD: 283503

## Issuer

- CIK: 0001867546
- Website: http://Entelexo.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2020-04-22
- Address: 5270 California Ave Ste 300, Irvine, CA, 92617
- Employees: 3

## Financials (as filed)

- Total assets (most recent): $357K
- Cash (most recent): $306K
- Net income (most recent): $-71K

## People (3)

| Name | Role | Location |
| --- | --- | --- |
| Charles Cameron Taylor | CTO | Irvine, CA |
| Milad Riazifar | CEO | Irvine, CA |
| Todd Schurr | COO | Irvine, CA |

## Reg CF filing history (2)

| Filed | Form | Target | Max |
| --- | --- | --- | --- |
| [2021-06-24](https://search.stillhousedata.com/formc/0001670254-21-000744) | C | $50K | $1.1M |

## More

- [CIK 1867546 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1867546&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001670254-21-000769.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.